Recent publications

de Jong, A. J. (2024). Bringing clinical trials home: European regulatory perspectives on decentralized clinical trial approaches. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2431

Van De Burgt, B. W. M., Wasylewicz, A. T. M., Dullemond, B., Jessurun, N. T., Grouls, R. J. E., Bouwman, R. A., Korsten, E. H. M., & Egberts, T. C. G. (2024). Development of a text mining algorithm for identifying adverse drug reactions in electronic health records. JAMIA Open, 7(3), Article ooae070. https://doi.org/10.1093/jamiaopen/ooae070

Schoenmakers, D. H., van den Berg, S., Timmers, L., Adang, L. A., Bäumer, T., Bosch, A., van de Casteele, M., Datema, M. R., Dekker, H., Donnelly, C., Driessens, M. H. E., Graessner, H., Greger, V., Haddad, T., Höglinger, G. U., van den Hout, H., Jonker, C., Langeveld, M., Lambert, L. J., ... Wolf, N. I. (2024). Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases. Neurology, 103(6), Article e209743. https://doi.org/10.1212/WNL.0000000000209743

Hogervorst, M. A., Soman, K. V., Gardarsdottir, H., Goettsch, W. G., & Bloem, L. T. (2024). Analytical Methods for Comparing Uncontrolled Trials with External Controls from Real-World Data: a Systematic Literature Review and Comparison to European Regulatory and Health Technology Assessment Practice. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2024.08.002

van Hulten, V., Souverein, P. C., Starup-Linde, J., Viggers, R., Klungel, O. H., Vestergaard, P., Brouwers, M. C. J. G., van den Bergh, J. P., & Driessen, J. H. M. (2024). The association of type 2 diabetes-related characteristics with fracture risk at different sites. Diabetes, Obesity and Metabolism. Advance online publication. https://doi.org/10.1111/dom.15884

van Nuland, M., Lobbezoo, A.-F. H., van de Garde, E. M. W., Herbrink, M., van Heijl, I., Bognàr, T., Houwen, J. P. A., Dekens, M., Wannet, D., Egberts, T., & van der Linden, P. D. (2024). Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100464. https://doi.org/10.1016/j.rcsop.2024.100464

Smale, E. M., Verkerk, E. W., Heerdink, E. R., Egberts, T. C. G., van den Bemt, B. J. F., & Bekker, C. L. (2024). Barriers and facilitators to implement the redispensing of unused oral anticancer drugs in clinical care: A hybrid-effectiveness type I study. Exploratory Research in Clinical and Social Pharmacy, 15, Article 100493. https://doi.org/10.1016/j.rcsop.2024.100493

Coppes, T., Hazen, A. C. M., Zwart, D. L. M., Koster, E. S., van Gelder, T., & Bouvy, M. L. (2024). Characteristics and preventability of medication-related admissions for acute kidney injury and dehydration in elderly patients. European Journal of Clinical Pharmacology, 80(9), 1355-1362. https://doi.org/10.1007/s00228-024-03704-7

The CHEERS-AI Steering Group, Elvidge, J., Hawksworth, C., Avşar, T. S., Zemplenyi, A., Chalkidou, A., Petrou, S., Petykó, Z., Srivastava, D., Chandra, G., Delaye, J., Gomes, M., Knies, S., Nousios, P., Siirtola, P., Wang, J., & Dawoud, D. (2024). Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI). Value in Health, 27(9), 1196-1205. https://doi.org/10.1016/j.jval.2024.05.006

Werkman, N. C. C., Driessen, J. H. M., Klungel, O. H., Schaper, N. S., Souverein, P. C., Stehouwer, C. D. A., & Nielen, J. T. H. (2024). Incretin-based therapy and the risk of diabetic foot ulcers and related events. Diabetes, Obesity and Metabolism, 26(9), 3764-3780. https://doi.org/10.1111/dom.15721

Coppes, T., Philbert, D., van Gelder, T., Bouvy, M. L., & Koster, E. S. (2024). Medication management during sick days: No differences between patients with and without impaired renal function. European Journal of Clinical Investigation, 54(9), Article e14231. https://doi.org/10.1111/eci.14231

van Nuland, M., Erdogan, A., Aςar, C., Contrucci, R., Hilbrants, S., Maanach, L., Egberts, T., & van der Linden, P. D. (2024). Performance of ChatGPT on Factual Knowledge Questions Regarding Clinical Pharmacy. Journal of Clinical Pharmacology, 64(9), 1095-1100. https://doi.org/10.1002/jcph.2443

Kempen, T. G. H., Benaissa, Y., Molema, H., Valk, L. E., Hazen, A. C. M., Heringa, M., Kwint, H.-F., Zwart, D. L. M., Sporrong, S. K., Stewart, D., & van Dijk, L. (2024). Pharmacists' current and potential prescribing roles in primary care in the Netherlands: a case study. Journal of Interprofessional Care, 38(5), 787-798. https://doi.org/10.1080/13561820.2024.2374017

Bennie, M., Santa-Ana-Tellez, Y., Galistiani, G. F., Trehony, J., Despres, J., Jouaville, L. S., Poluzzi, E., Morin, L., Schubert, I., MacBride-Stewart, S., Elseviers, M., Nasuti, P., & Taxis, K. (2024). The prevalence of polypharmacy in older Europeans: A multi-national database study of general practitioner prescribing. British Journal of Clinical Pharmacology, 90(9), 2124-2136. https://doi.org/10.1111/bcp.16113

Ferreira Martins, M. L., Heydari, P., Li, W., Martinez-Chavez, A., el Yattouti, M., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2024). The role of drug efflux and uptake transporters in the plasma pharmacokinetics and tissue disposition of morphine and its main metabolites. Toxicology and Applied Pharmacology, 490, 1-14. Article 117040. https://doi.org/10.1016/j.taap.2024.117040

Julian, E., Solà-Morales, O., Garcia, M. J., Brinkhuis, F., Pavlovic, M., Martín-Saborido, C., Doeswijk, R., Giuliani, R., Willemsen, A., Goettsch, W., Wörmann, B., Dafni, U., Bucher, H. C., Pérez-Valderrama, B., Bernardini, R., Gianfrate, F., Uyl-de Groot, C. A., & Ruof, J. (2024). The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights Generated at the 2023 Fall Convention and Survey of the European Access Academy. Journal of market access & health policy, 12(3), 128-143. https://doi.org/10.3390/jmahp12030011

on behalf of the COSEB Consortium, Korte, E. W. H., Pasmooij, A. M. G., Bolling, M. C., Hickey, S., Hussain, S., Kiritsi, D., Kottner, J., Prinsen, C. A. C., Sauvestre, A., Sendin, G., Spuls, P. I., Tarrats, N., Wally, V., Welponer, T., Laimer, M., & Van Den Akker, P. C. (2024). Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa. British Journal of Dermatology, 191(3), 463-465. https://doi.org/10.1093/bjd/ljae200

DECISION Investigators and Committees, van Veldhuisen, D. J., Rienstra, M., Mosterd, A., Alings, A. M., van Asselt, A. D. J., Bouvy, M. L., Tijssen, J. G. P., Schaap, J., van der Wall, E. E., Voors, A. A., Boorsma, E. M., Lok, D. J. A., Crijns, H. J. G. M., Schut, A., Vijver, M. A. T., Voordes, G. H. D., de Vos, A. H., Maas-Soer, E. L., ... van der Meer, P. (2024). Efficacy and safety of low-dose digoxin in patients with heart failure. Rationale and design of the DECISION trial. European Journal of Heart Failure. Advance online publication. https://doi.org/10.1002/ejhf.3428

Arnamo, A. H., Pluim, D., Huitema, A. D. R., Jacobs, B. A. W., Beijnen, J. H., & Nuijen, B. (2024). Prolonged in-use physicochemical and biological stability of nivolumab and pembrolizumab diluted in saline infusion bags and in partially used medication vials. Journal of Oncology Pharmacy Practice. Advance online publication. https://doi.org/10.1177/10781552241279018

Costa, E., Girotti, S., Mathieu, C., Castellani, C., Ross, J. S., Taylor-Cousar, J. L., & Leufkens, H. G. M. (2024). Differential times of submission and approval of CFTR modulators for the treatment of Cystic Fibrosis in the United States and the European Union. Journal of Cystic Fibrosis. Advance online publication. https://doi.org/10.1016/j.jcf.2024.08.002

Ogar, C. K., Gilbert, H. N., Bloem, L. T., Leopold, C., Bassi, P. U., Katagum, Y. M., Osakwe, A. I., Opadeyi, A. O., Oreagba, I., Mbo, D. N. D., Mantel-Teeuwisse, A. K., & De Bruin, M. L. (2024). Patient-reported outcomes of adverse events after COVID-19 vaccination in Nigeria: A mixed methods study. Vaccine, 42(23), Article 126196. Advance online publication. https://doi.org/10.1016/j.vaccine.2024.126196

Falke, C., Karapinar, F., Bouvy, M., Emmelot, M., Belitser, S., Boland, B., O’Mahony, D., Murphy, K. D., Haller, M., Salari, P., Schwenkglenks, M., Rodondi, N., Egberts, T., & Knol, W. (2024). The association between medication use and health-related quality of life in multimorbid older patients with polypharmacy. European Geriatric Medicine. Advance online publication. https://doi.org/10.1007/s41999-024-01036-4

Iversen, D. B., Dunvald, A.-C. D., Ernst, M. T., Abtahi, S., Souverein, P., Klungel, O., Jeppesen, G. B., Nielsen, F., Brøsen, K., Hammer, H. S., Pötz, O., Damkier, P., Järvinen, E., Pottegård, A., & Stage, T. B. (2024). Dicloxacillin is an inducer of intestinal P-glycoprotein but neither dicloxacillin nor flucloxacillin increases the risk of stroke/systemic embolism in direct oral anticoagulant users. British Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1111/bcp.16190

Bloem, L. T., Van der Elst, M. E., & Klungel, O. H. (2024). Principles of Pharmacovigilance and Drug Regulation. In J. Jose, A. R. Cox, & V. Paudyal (Eds.), Principles and Practice of Pharmacovigilance and Drug Safety (pp. 135-161). Springer. https://doi.org/10.1007/978-3-031-51089-2_6

Lentzas, A., de Gooijer, M. C., Zuidema, S., Meurs, A., Çitirikkaya, C. H., Venekamp, N., Beijnen, J. H., & van Tellingen, O. (2024). ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brain. Fluids and Barriers of the CNS, 21(1), Article 62. https://doi.org/10.1186/s12987-024-00562-4

Jadoenathmisier, K. D., Stoyanova-Beninska, V., Soons, I. M., Leufkens, H. G., Bloem, L. T., & Pasmooij, A. M. (2024). Feasibility of disease terminology systems for mapping orphan conditions and therapeutic indications of designated orphan medicines in the European Union. European Journal of Pharmaceutical Sciences, 202, Article 106871. Advance online publication. https://doi.org/10.1016/j.ejps.2024.106871

Ellerbroek, H., Schellekens, A. F. A., Kalkman, G. A., Visser, D. A., Kramers, C., Dahan, A., van den Heuvel, S. A. S., Bouvy, M. L., & van Dorp, E. L. A. (2024). Opioid prescribing in the Netherlands during the COVID-19 pandemic: a national register-based study. BMJ Open, 14(8), Article e082369. https://doi.org/10.1136/bmjopen-2023-082369

Embaby, A., Huijberts, S. C. F. A., Wang, L., de Oliveira, R. L., Rosing, H., Nuijen, B., Sanders, J., Hofland, I., van Steenis, C., Kluin, R. J. C., Lieftink, C., Smith, C. G., Blank, C. U., van Thienen, J. V., Haanen, J. B. A. G., Steeghs, N., Opdam, F. L., Beijnen, J. H., Huitema, A. D. R., ... Wilgenhof, S. (2024). A Proof-of-Concept Study of Sequential Treatment with the HDAC Inhibitor Vorinostat following BRAF and MEK Inhibitors in BRAFV600-Mutated Melanoma. Clinical Cancer Research, 30(15), 3157-3166. https://doi.org/10.1158/1078-0432.CCR-23-3171

Schouten, W. M., Roseboom, I. C., Lucas, L., Kabalu Tshiongo, J., Muhindo Mavoko, H., Kayentao, K., Rosing, H., Huitema, A. D. R., Beijnen, J. H., & Dorlo, T. P. C. (2024). Development and validation of an ultra-performance liquid chromatography-tandem mass spectrometry method for the quantification of the antimalarial drug pyronaridine in human whole blood. Journal of Pharmaceutical and Biomedical Analysis, 245, Article 116154. https://doi.org/10.1016/j.jpba.2024.116154

Meertens, M., de Vries, N., Rosing, H., Steeghs, N., Beijnen, J. H., & Huitema, A. D. R. (2024). Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites. Therapeutic Drug Monitoring, 46(4), 494-502. https://doi.org/10.1097/FTD.0000000000001175

Manson, L. E. N., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D. J., van Westrhenen, R., Deneer, V. H. M., & Guchelaar, H. J. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction of CYP2C9, HLA-A and HLA-B with anti-epileptic drugs. European Journal of Human Genetics, 32(8), 903-911. https://doi.org/10.1038/s41431-024-01572-4

Callenbach, M. H. E., Schoenmakers, D., Vreman, R. A., Vijgen, S., Timmers, L., Hollak, C. E. M., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Illustrating the financial consequences of outcome-based payment models from a payers perspective- the case of autologous gene therapy atidarsagene autotemcel (Libmeldy®). Value in Health, 27(8), 1046-1057. https://doi.org/10.1016/j.jval.2024.05.010

Tillemans, M. P. H., Giezen, T. J., Egberts, T. C. G., Hooijberg, J. H., & Kalisvaart, K. J. (2024). Intranasal vitamin B12 administration in elderly patients: A randomized controlled comparison of two dosage regimens. British Journal of Clinical Pharmacology, 90(8), 1975-1983. https://doi.org/10.1111/bcp.16084

Sadreghaemy, M., Gamba, M. A., Bloem, L. T., & Egberts, T. C. G. (2024). Leftover of Amoxicillin Suspension After Use by Children in the Netherlands. Pharmacoepidemiology and Drug Safety, 33(8), Article e5868. https://doi.org/10.1002/pds.5868

Weir, D. L., Bai, Y. Q., Thavorn, K., Guilcher, S., Kanji, S., Mulpuru, S., & Wodchis, W. (2024). Non-adherence to COPD medications and its association with adverse events: A longitudinal population based cohort study of older adults. Annals of Epidemiology, 96, 88-96. https://doi.org/10.1016/j.annepidem.2023.12.003

Eroglu, TE., Coronel, R., & Gislason, GH. (2024). Use of proton pump inhibitors is associated with increased risk of out-of-hospital cardiac arrest in the general population: a nested case-control study. European Heart Journal - Cardiovascular Pharmacotherapy, 10(5), 413-419. https://doi.org/10.1093/ehjcvp/pvae020

Avşar, T. S., Elvidge, J., Hawksworth, C., Kenny, J., Németh, B., Callenbach, M., Ringkvist, J., & Dawoud, D. (2024). Linking Reimbursement to Patient Benefits for Advanced Therapy Medicinal Products and Other High-Cost Innovations: Policy Recommendations for Outcomes-Based Agreements in Europe. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2024.07.007

Bognàr, T., Garcia-Rosa, M., Lalmohamed, A., Güngör, T., Hauri-Hohl, M. M., Prockop, S. E., Oram, L. M., Pai, S.-Y., Brooks, J., Savic, R. M., Dvorak, C. C., Long-Boyle, J. R., Krajinovic, M., Bittencourt, H., Teyssier, A.-C., Theoret, Y., Martinez, C., Egberts, T. C. G., Morales, E., ... Bartelink, I. H. (2024). Association of Busulfan Exposure and Outcomes after HCT for Patients with an Inborn Error of Immunity. Blood advances. Advance online publication. https://doi.org/10.1182/bloodadvances.2024013275

Bognàr, T., Bartelink, I. H. I., van der Elst, K. C. M., Kingma, J. S., Smeijsters, E. H., Lindemans, C. A. C., Egberts, A. C. G. T., Kuball, J. H. E., de Witte, M. A., De Vries Schultink, A. H. M., & Lalmohamed, A. (2024). Busulfan exposure target attainment in adults undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiple day therapeutic drug monitoring regimen. Transplantation and Cellular Therapy. Advance online publication. https://doi.org/10.1016/j.jtct.2024.07.015

Bouma, R. G., Twilhaar, M. K. N., Brink, H. J., Affandi, A. J., Mesquita, B. S., Olesek, K., van Dommelen, J. M. A., Heukers, R., de Haas, A. M., Kalay, H., Ambrosini, M., Metselaar, J. M., van Rooijen, A., Storm, G., Oliveira, S., van Kooyk, Y., & den Haan, J. M. M. (2024). Nanobody-liposomes as novel cancer vaccine platform to efficiently stimulate T cell immunity. International Journal of Pharmaceutics, 660, 1-13. Article 124254. https://doi.org/10.1016/j.ijpharm.2024.124254

Hoek, J. M., Brenninkmeijer, J., de Vries, Y. A., Meijer, R. R., & van Ravenzwaaij, D. (2024). Assessing the credibility of a drug's effects: identification and judgment of uncertainty by the Dutch Medicines Evaluation Board. Frontiers in Medicine, 11, 1-13. Article 1409259. https://doi.org/10.3389/fmed.2024.1409259

Meijvis, V. A. M., Heringa, M., Kwint, H.-F., de Wit, N. J., & Bouvy, M. L. (2024). Factors influencing the implementation of the CombiConsultation in Dutch clinical practice: a mixed-methods study. International Journal of Pharmacy Practice, 32(5), 347-354. Advance online publication. https://doi.org/10.1093/ijpp/riae032

Opalska, A., Gardarsdottir, H., Kwa, M., Wojkowska-Mach, J., Sabate, M., Ballarin, M. E., de Groot, M., & Leufkens, H. (2024). Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic. European Journal of Clinical Pharmacology. Advance online publication. https://doi.org/10.1007/s00228-024-03726-1

Grupstra, R. J., Goedecke, T., & Gardarsdottir, H. (2024). Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety Studies. Clinical Pharmacology & Therapeutics. Advance online publication. https://doi.org/10.1002/cpt.3369

Lin, L., van der Noort, V., Steeghs, N., Ruiter, G., Beijnen, J. H., & Huitema, A. D. R. (2024). A joint model of longitudinal pharmacokinetic and time-to-event data to study exposure-response relationships: a proof-of-concept study with alectinib. Cancer Chemotherapy and Pharmacology. Advance online publication. https://doi.org/10.1007/s00280-024-04698-w

van Loon, W. E., Lambert, M., Heringa, M., Bouvy, M. L., & Taxis, K. (2024). Community pharmacists' attitudes towards checking prescriptions: a cross-sectional survey. The International Journal of Pharmacy Practice, 32(5), 363-368. Article riae030. Advance online publication. https://doi.org/10.1093/ijpp/riae030

Versteeg, J.-W., Vreman, R., Mantel-Teeuwisse, A., & Goettsch, W. (2024). Uncertainty In Long-term Relative Effectiveness Of Medicines In Health Technology Assessment: Comparing Assessments Of Medicines For Spinal Muscular Atrophy, Cystic Fibrosis, And Hypercholesterolemia. Value in Health. Advance online publication. https://doi.org/10.1016/j.jval.2024.05.023

Beunk, L., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Guchelaar, H.-J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., Deneer, V. H. M., & van Westrhenen, R. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP2C19 and non-SSRI/non-TCA antidepressants. European Journal of Human Genetics, 1-7. Advance online publication. https://doi.org/10.1038/s41431-024-01648-1

Brinkhuis, F., Julian, E., van den Ham, H., Gianfrate, F., Strammiello, V., Berntgen, M., Pavlovic, M., Mol, P., Wasem, J., Van Dyck, W., Cardone, A., Dierks, C., Schiel, A., Bernardini, R., Solà-Morales, O., Ruof, J., & Goettsch, W. (2024). Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy. Health Research Policy and Systems, 22(1), Article 74. https://doi.org/10.1186/s12961-024-01154-2

Pieters, T. (2024). ‘Help ik ben besmet’ De illusie doorgeprikt van een ‘intelligente’ lockdown. Tijdschrift Voor Geschiedenis, 137(2), 205-214. https://doi.org/10.5117/TVG2024.2.009.PIET

Mertens, J. F., Kempen, T. G. H., Koster, E. S., Deneer, V. H. M., Bouvy, M. L., & van Gelder, T. (2024). Pharmacists and pharmacy students' perceptions on how a new teaching model supports their clinical decision-making. Currents in Pharmacy Teaching and Learning, 16(10), Article 102136. Advance online publication. https://doi.org/10.1016/j.cptl.2024.102136

Madrid Paredes, J., Versteeg, J.-W., Vreman, R. A., & Bloem, L. T. (2024). Agreement about Availability of Alternative Treatments for Innovative Drugs Assessed by the EMA and HTA Organizations. Clinical Pharmacology and Therapeutics, 116(1), 136-146. https://doi.org/10.1002/cpt.3252

Jacobs, T. G., Okemo, D., Ssebagereka, A., Mwehonge, K., Njuguna, E. M., Burger, D. M., Colbers, A., Suleman, F., Mantel-Teeuwisse, A. K., & Ooms, G. I. (2024). Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda. HIV Medicine, 25(7), 805-816. https://doi.org/10.1111/hiv.13635

Callenbach, M. H. E., Goettsch, W. G., Mantel-Teeuwisse, A. K., & Trusheim, M. (2024). Creating win-win-win situations with managed entry agreements? Prioritizing gene and cell therapies within the window of opportunity. Drug Discovery Today, 29(7), Article 104048. https://doi.org/10.1016/j.drudis.2024.104048

Hogervorst, M. A., van Hattem, C. C., Sonke, G. S., Mantel-Teeuwisse, A. K., Goettsch, W. G., & Bloem, L. T. (2024). Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned. Drug Discovery Today, 29(7), Article 104031. https://doi.org/10.1016/j.drudis.2024.104031

Loos, NHC., Bui, V., de Jong, DH., Lebre, MC., Rosing, H., Beijnen, JH., & Schinkel, AH. (2024). Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy: a preclinical assessment. Cancer Chemotherapy and Pharmacology, 94(1), 79-87. https://doi.org/10.1007/s00280-024-04662-8

Davies, L. E. M., Jansen-Groot Koerkamp, E. A. W., Koster, E. S., Dalusong, K.-J., Koch, B., Schellekens, A., Heringa, M., & Bouvy, M. (2024). Patients' perspectives about the role of primary healthcare providers in long-term opioid therapy: a qualitative study in Dutch primary care. British Journal of General Practice, 74(744), e475-e481. https://doi.org/10.3399/BJGP.2023.0547

van Nuland, M., Snoep, J. J. D., Egberts, T., Erdogan, A., Wassink, R., & van der Linden, P. D. (2024). Poor performance of ChatGPT in clinical rule-guided dose interventions in hospitalized patients with renal dysfunction. European Journal of Clinical Pharmacology, 80(8), 1133-1140. https://doi.org/10.1007/s00228-024-03687-5

Eroglu, T. E., Coronel, R., & Souverein, P. C. (2024). Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study. European heart journal. Cardiovascular pharmacotherapy, 10(4), 289-295. https://doi.org/10.1093/ehjcvp/pvae022

Pasmooij, A. M. G., Mol, P. G. M., Bot, J. C., & Leufkens, H. G. M. (2024). The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report. Clinical Pharmacology and Therapeutics, 116(1), 64-71. https://doi.org/10.1002/cpt.3275

van de Voort, T., Moors, E., Hoekman, J., & Bloem, L. T. (2024). Understanding the transformative nature of initiatives challenging the traditional pharmaceutical model in the gene and cell therapy field. Abstract from EASST-4S 2024 Conference, Amsterdam, Netherlands.

Kanning, J. P., Abtahi, S., Schnier, C., Klungel, O. H., Geerlings, M. I., & Ruigrok, Y. M. (2024). Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study. Neurology, 102(12), Article e209479. https://doi.org/10.1212/WNL.0000000000209479

Grupstra, R. J., Siiskonen, S. J., & Gardarsdottir, H. (2024). Risicominimalisatiemaatregelen voor geneesmiddelen. Nederlands Tijdschrift voor Geneeskunde, 168.

Maksimova, M. V., van Thiel, G. J. M. W., Tromp, Y., Lechner, R., van Delden, J. J. M., & Bloem, L. T. (2024). Balancing ethical norms and duties for the introduction of new medicines through conditional marketing authorization: a research agenda. Frontiers in Medicine, 11, Article 1408553. https://doi.org/10.3389/fmed.2024.1408553

Jansen-Groot Koerkamp, E. A. W., Weesie, Y. M., Heringa, M., Hek, K., Blom, J. W., Numans, M. E., van Dijk, L., & Bouvy, M. L. (2024). General practitioners' and community pharmacists' beliefs and practices on opioids for non-malignant pain. European Journal of Pain (United Kingdom). Advance online publication. https://doi.org/10.1002/ejp.2304

van den Broek, W. W. A., Gimbel, M. E., Hermanides, R. S., Runnett, C., Storey, R. F., Knaapen, P., Emans, M. E., Oemrawsingh, R. M., Cooke, J., Galasko, G., Walhout, R., Stoel, M. G., von Birgelen, C., van Bergen, P. F. M. M., Brinckman, S. L., Aksoy, I., Liem, A., van't Hof, A. W. J., Jukema, J. W., ... ten Berg, J. M. (2024). The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome. International Journal of Cardiology, 405, Article 131940. https://doi.org/10.1016/j.ijcard.2024.131940

De Graef, M., Serraes, B., Van Rompay, V., Dijkstra, N. E., Heerdink, E. R., & Dilles, T. (2024). Implementation of Pharmaceutical Technical Assistants on Hospital Wards and Their Impact on Patient Safety and Quality of Care: A Qualitative Study on Nurses' Experiences and Perceptions. Journal of Nursing Management, 2024, Article 7894331. https://doi.org/10.1155/2024/7894331

Schoegje, T., Hardman, L., Vries, A. D., & Pieters, T. (2024). Reconstructing the decision-making processes of a city council based on references between documents. In H.-C. Liao, D. D. Cid, M. A. Macadar, & F. Bernardini (Eds.), dg.o '24: Proceedings of the 25th Annual International Conference on Digital Government Research (pp. 525-533). (ACM International Conference Proceeding Series). Association for Computing Machinery . https://doi.org/10.1145/3657054.3657116

Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). A proposed analytical framework for qualitative evaluation of access to medicines from a health systems perspective. BMC Research Notes, 17(1), Article 159. https://doi.org/10.1186/s13104-024-06764-1

Rijmers, J., Retmana, I. A., Bui, V., Arguedas, D., Lebre, M. C., Sparidans, R. W., Beijnen, J. H., & Schinkel, A. H. (2024). ABCB1 attenuates brain exposure to the KRASG12C inhibitor opnurasib whereas binding to mouse carboxylesterase 1c influences its plasma exposure. Biomedicine and Pharmacotherapy, 175, Article 116720. https://doi.org/10.1016/j.biopha.2024.116720

Annema, P. A., Derijks, H. J., Bouvy, M. L., & van Marum, R. J. (2024). Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis. Clinical Pharmacology and Therapeutics, 115(6), 1365-1371. https://doi.org/10.1002/cpt.3220

Shea, B., Pardo, J. P., Grosskleg, S., Beaton, D. E., Conaghan, P., Goettsch, W., Hofstetter, C., Maxwell, L., Musaus, J., Ollendorf, D., Schultz, G., Stevens, R., Strand, V., Tugwell, P., Williamson, P., Tunis, S., & Simon, L. S. (2024). Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023. Seminars in Arthritis and Rheumatism, 66, Article 152438. https://doi.org/10.1016/j.semarthrit.2024.152438

Li, W., Sparidans, R. W., Wang, Y., Martins, M. L. F., de Waart, D. R., van Tellingen, O., Song, J.-Y., Lebre, M. C., van Hoppe, S., Wagenaar, E., Beijnen, J. H., & Schinkel, A. H. (2024). Interplay of OATP1A/1B/2B1 uptake transporters and ABCB1 and ABCG2 efflux transporters in the handling of bilirubin and drugs. Biomedicine and Pharmacotherapy, 175, Article 116644. https://doi.org/10.1016/j.biopha.2024.116644

Kempen, T. G. H., van Dijk, L., Floor-Schreudering, A., Kohli, A., Kwint, H. F., Schackmann, L., van Tuyl, L. H. D., & Heringa, M. (2024). Potential for pharmacist prescribing in primary care: A Dutch citizen perspective. Exploratory Research in Clinical and Social Pharmacy, 14, Article 100453. https://doi.org/10.1016/j.rcsop.2024.100453

Jansen, M. S., Dekkers, O. M., le Cessie, S., Hooft, L., Gardarsdottir, H., de Boer, A., & Groenwold, R. H. H. (2024). Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review. Clinical Pharmacology and Therapeutics, 115(6), 1269-1276. https://doi.org/10.1002/cpt.3218

van Gelder, T. G., van Diem-Zaal, I. J., Dijkstra-Kersten, S. M. A., de Mul, N., Lalmohamed, A., & Slooter, A. J. C. (2024). The risk of delirium after sedation with propofol or midazolam in intensive care unit patients. British Journal of Clinical Pharmacology, 90(6), 1471-1479. https://doi.org/10.1111/bcp.16031

Lin, L., Houwink, A. P. I., van Dieren, J. M., Wolthuis, E. K., van Thienen, J. V., van der Heijden, M. S., Haanen, J. B. A. G., Beijnen, J. H., & Huitema, A. D. R. (2024). Treatment patterns and survival outcomes of patients admitted to the intensive care unit due to immune-related adverse events of immune checkpoint inhibitors. Cancer Medicine, 13(12), 1-7. Article e7302. https://doi.org/10.1002/cam4.7302

Joosse, I. R. (2024). Forging new paths in access to medicines research: Towards equitable access for all. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2303

Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., Vreman, R. A., Largeron, N., Banhazi, J., Ollendorf, D. A., Jain, M., Upadhyaya, S., & Goettsch, W. G. (2024). An operationalization framework for lifecycle HTA. International Journal of Technology Assessment in Health Care. Advance online publication. https://doi.org/10.1017/S0266462324000199

Meijvis, V. A. M. (2024). The CombiConsultation: Patient-centred pharmaceutical care by interprofessional collaboration. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2200

Arnoldy, L., Gauci, S., Lassemillante, A.-C. M., Verster, J. C., Macpherson, H., Minihane, A.-M., Scholey, A., Pipingas, A., & White, D. J. (2024). Towards Consistency in Dietary Pattern Scoring: Standardising Scoring Workflows for Mediterranean, DASH, and MIND Diets Using 24-Hour Recall and Two Variations of a Food Frequency Questionnaire. British Journal of Nutrition, 131(9), 1554-1577. https://doi.org/10.1017/S0007114524000072

Chandra, G., Wang, JF., Siirtola, P., & Röning, J. (2024). Leveraging machine learning for predicting acute graft-versus-host disease grades in allogeneic hematopoietic cell transplantation for T-cell prolymphocytic leukaemia. BMC Medical Research Methodology, 24(1), Article 112. https://doi.org/10.1186/s12874-024-02237-y

Pichler, F. B., Boysen, M., Mittmann, N., Gilardino, R., Bruce, A., Bond, K., Vreman, R. A., Largeron, N., Banhazi, J., Ollendorf, D. A., Jain, M., Upadhyaya, S., & Goettsch, W. G. (2024). Lifecycle HTA: Promising applications and a framework for implementation. International Journal of Technology Assessment in Health Care. Advance online publication. https://doi.org/10.1017/S0266462324000187

Ooms, G. I., Usman, M. A., Reed, T., van den Ham, H. A., & Mantel-Teeuwisse, A. K. (2024). The impact of scheduling ketamine as an internationally controlled substance on anaesthesia care in Sub-Saharan Africa: a case study and key informant interviews. BMC Health Services Research, 24(1), Article 598. https://doi.org/10.1186/s12913-024-11040-w

Gini, R., Pajouheshnia, R., Gardarsdottir, H., Bennett, D., Li, L., Gulea, C., Wientzek-Fleischmann, A., Bazelier, M. T., Burcu, M., Dodd, C., Durán, C. E., Kaplan, S., Lanes, S., Marinier, K., Roberto, G., Soman, K., Zhou, X., Platt, R., Setoguchi, S., & Hall, G. C. (2024). Describing diversity of real world data sources in pharmacoepidemiologic studies: The DIVERSE scoping review. Pharmacoepidemiology and Drug Safety, 33(5), Article e5787. https://doi.org/10.1002/pds.5787

Schultze, A., Martin, I., Messina, D., Bots, S., Belitser, S., José Carreras-Martínez, J., Correcher-Martinez, E., Urchueguía-Fornes, A., Martín-Pérez, M., García-Poza, P., Villalobos, F., Pallejà-Millán, M., Alberto Bissacco, C., Segundo, E., Souverein, P., Riefolo, F., Durán, C. E., Gini, R., Sturkenboom, M., ... Douglas, I. (2024). A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases. Vaccine, 42(12), 3039-3048. https://doi.org/10.1016/j.vaccine.2024.03.043

Kalf, R. (2024). Improving patient access to valuable new pharmaceuticals: Working towards and evidence ecosystem in healthcare. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2182

Dutch Multiuse Dis Modeling (2024). A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations. PharmacoEconomics, 42(7), 797-810. https://doi.org/10.1007/s40273-024-01376-w

Leopold, C., Vogler, S., Suleman, F., & Wirtz, V. J. (2024). P38 Strengthening primary health care through a stronger emphasis on patient and community centered medicines and pharmaceutical services. Journal of Pharmaceutical Policy and Practice, 17(1), Article 2331920. https://doi.org/10.1080/20523211.2024.2331920

Loos, N. H. C. (2024). Relevance of pharmacological boosters in the disposition of oral anticancer drugs: Mouse models. [Doctoral thesis 2 (Research NOT UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/2190

Raethke, M., van Hunsel, F., Luxi, N., Lieber, T., Bellitto, C., Mulder, E., Ciccimarra, F., Riefolo, F., Thurin, N. H., Roy, D., Morton, K., Villalobos, F., Batel Marques, F., Farcas, A., Sonderlichová, S., Belitser, S., Klungel, O., Trifirò, G., & Sturkenboom, M. C. (2024). Frequency and timing of adverse reactions to COVID-19 vaccines; A multi-country cohort event monitoring study. Vaccine, 42(9), 2357-2369. https://doi.org/10.1016/j.vaccine.2024.03.001

Verweij, S., Haverhoek, V., Bergman, E., Westman, G., & Bloem, L. T. (2024). A Natural Language Processing Approach towards Harmonized Communication of Uncertainties Identified during the European Medicine Authorization Process. Clinical Pharmacology and Therapeutics, 115(4), 871-880. https://doi.org/10.1002/cpt.3195

Schackmann, L., Koster, E. S., van Dijk, L., Vervloet, M., & Heringa, M. (2024). Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences. International Journal of Clinical Pharmacy, 46(2), 439-450. https://doi.org/10.1007/s11096-023-01664-z

Werkman, N. C. C., García-Sáez, G., Nielen, J. T. H., Tapia-Galisteo, J., Somolinos-Simón, F. J., Hernando, M. E., Wang, J., Jiu, L., Goettsch, W. G., van der Kallen, C. J. H., Koster, A., Schalkwijk, C. G., de Vries, H., de Vries, N. K., Eussen, S. J. P. M., Driessen, J. H. M., & Stehouwer, C. D. A. (2024). Disease severity-based subgrouping of type 2 diabetes does not parallel differences in quality of life: the Maastricht Study. Diabetologia, 67(4), 690-702. https://doi.org/10.1007/s00125-023-06082-4

Loos, N. H. C., Sparidans, R. W., Heydari, P., Bui, V., Lebre, M. C., Beijnen, J. H., & Schinkel, A. H. (2024). The ABCB1 and ABCG2 efflux transporters limit brain disposition of the SYK inhibitors entospletinib and lanraplenib. Toxicology and Applied Pharmacology, 485, Article 116911. https://doi.org/10.1016/j.taap.2024.116911

Lalmohamed, A., Venekamp, R. P., Bolhuis, A., Souverein, P. C., van de Wijgert, J. H. H. M., Gulliford, M. C., & Hay, A. D. (2024). Within-episode repeat antibiotic prescriptions in patients with respiratory tract infections: A population-based cohort study. The Journal of Infection, 88(4), Article 106135. https://doi.org/10.1016/j.jinf.2024.106135

Jiu, L. (2024). Innovating Health Technology Assessment Methods: Barriers and Enablers illustrated using Qualitative and Quantitative Methods on Real-World Data. [Doctoral thesis 1 (Research UU / Graduation UU), Universiteit Utrecht]. Utrecht University. https://doi.org/10.33540/1310

Metselaar-Albers, M., Meijerman, I., Engels, F., Haanen, J., Beijnen, J., & Lalmohamed, A. (2024). No detrimental association between antibiotic use and immune checkpoint inhibitor therapy: an observational cohort study comparing patients with ICI-treated and TKI-treated melanoma and NSCLC. Journal for ImmunoTherapy of Cancer, 12(1), Article e008269. https://doi.org/10.1136/jitc-2023-008269

van Paassen, J., Tan, J., Deneer, V., & Bouvy, M. (2024). Exploring the pharmacists' role in optimising antithrombotic therapy in primary care: a qualitative study. BMJ Open, 14(3), Article e079018. https://doi.org/10.1136/bmjopen-2023-079018

Vogler, S., Leopold, C., Suleman, F., & Wirtz, V. J. (2024). Medicines and pharmaceutical services. In Implementing the Primary Health Care approach: a primer (pp. 249-273). European Observatory on Health Systems and Policies, WHO Headquarters (HQ). https://eurohealthobservatory.who.int/publications/i/implementing-the-primary-health-care-approach-a-primer

Schoegje, T., Hardman, L., De Vries, A., & Pieters, T. (2024). Improving expert search effectiveness: Comparing ways to rank and present search results. In CHIIR 2024 - Proceedings of the 2024 Conference on Human Information Interaction and Retrieval (pp. 56-65). (CHIIR 2024 - Proceedings of the 2024 Conference on Human Information Interaction and Retrieval). Association for Computing Machinery . https://doi.org/10.1145/3627508.3638296

den Hartog, I., Zwep, LB., Meulman, JJ., Hankemeier, T., van de Garde, EMW., & van Hasselt, JGC. (2024). Longitudinal metabolite profiling of <i>Streptococcus pneumoniae</i>-associated community-acquired pneumonia. Metabolomics, 20(2), Article 35. https://doi.org/10.1007/s11306-024-02091-5

Van Gelder, T. G., Lalmohamed, A., Dorst-Mooiman, K. D., Dekker, J. C., Schinkel, M. J., Sikma, M. A., Uijtendaal, E. V., Kemper, M. M., & Egberts, T. C. G. (2024). Significante daling in verspilling RTA-spuiten. Pharmaceutisch Weekblad, 159(9), 15-17. https://www.pw.nl/achtergrond/2024/significante-daling-in-verspilling-rta-spuiten

Dankers, M., Hek, K., Mantel-Teeuwisse, A. K., van Dijk, L., & Nelissen-Vrancken, M. H. J. M. G. (2024). Adoption of new medicines in primary care: A comparison between the uptake of new oral anticoagulants and diabetes medicines. British Journal of Clinical Pharmacology, 90(3), 819-827. https://doi.org/10.1111/bcp.15959

Jiu, L., Wang, J., Javier Somolinos-Simón, F., Tapia-Galisteo, J., García-Sáez, G., Hernando, M., Li, X., Vreman, R. A., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). A literature review of quality assessment and applicability to HTA of risk prediction models of coronary heart disease in patients with diabetes. Diabetes Research and Clinical Practice, 209, Article 111574. https://doi.org/10.1016/j.diabres.2024.111574

Desmet, T., Julian, E., Van Dyck, W., Huys, I., Simoens, S., Giuliani, R., Toumi, M., Dierks, C., Dierks, J., Cardone, A., Houÿez, F., Pavlovic, M., Berntgen, M., Mol, P., Schiel, A., Goettsch, W., Gianfrate, F., Capri, S., Ryan, J., ... Ruof, J. (2024). An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. Journal of market access & health policy, 12(1), 21-34. https://doi.org/10.3390/jmahp12010004

Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J. P., & Vestergaard, P. (2024). Fracture patterns and associated risk factors in pediatric and early adulthood type 1 diabetes: Findings from a nationwide retrospective cohort study. Bone, 180, 1-9. Article 116997. https://doi.org/10.1016/j.bone.2023.116997

Joosse, I. R., Mantel-Teeuwisse, A. K., Suleman, F., & van den Ham, H. A. (2024). Monitoring Access to Child Medicines: Introducing a Standardized Set of Age-Appropriate Medicines. Children, 11(3), Article 266. https://doi.org/10.3390/children11030266

Trials@Home Consortium (2024). Opportunities and challenges for decentralized clinical trial approaches: European health technology assessment perspective. Value in Health, 27(3), 294-300. https://doi.org/10.1016/j.jval.2023.11.006

Verschueren, M. V., Peters, B. J., Bloem, L. T., Kruik, V. R., Uitvlugt, E. B., Bijsmans, A. R., Egberts, A. C., & van de Garde, E. M. (2024). Pembrolizumab Plus Chemotherapy Per PD-L1 Stratum In Patients With Metastatic Non-Small Cell Lung Cancer: Real-World Effectiveness Versus Trial Efficacy. Clinical Lung Cancer, 25(2), 119-127.e1. https://doi.org/10.1016/j.cllc.2023.12.011

Molewijk, E., Fliers, E., Dreijerink, K., van Dooren, A., & Heerdink, R. (2024). Quality of life, daily functioning, and symptoms in hypothyroid patients on thyroid replacement therapy: A Dutch survey. Journal of Clinical and Translational Endocrinology, 35, 1-10. Article 100330. https://doi.org/10.1016/j.jcte.2024.100330

Rijt-Weetink, Y. R. J. V., Egberts, T. C. G., Hunsel, F. P. A. M. V., Lewis, D. J., Yates, L. M., Winterfeld, U., & Puijenbroek, E. P. V. (2024). Validation of a Novel Method to Assess the Clinical Quality of Information in Pregnancy-Related Pharmacovigilance Case Reports: A ConcePTION Project. Drug Safety, 47(3), 261-270. https://doi.org/10.1007/s40264-023-01389-y

Abraham, K., Kvamme, I., Magrin Sammut, S., de Vries, S., Formosa, T., Dupree, R., Corro Ramos, I., Goettsch, W., & Franken, M. (2024). A blueprint for health technology assessment capacity building: lessons learned from Malta. International Journal of Technology Assessment in Health Care, 40(1), Article e11. https://doi.org/10.1017/S0266462324000072

Brinkhuis, F., Goettsch, W. G., Mantel - Teeuwisse, A., & Bloem, L. T. (2024). High cost oncology drugs without proof of added benefit are burdening health systems. The BMJ, 384, Article q511. https://doi.org/10.1136/bmj.q511

Loos, NHC., Martins, MLF., Rijmers, J., de Jong, D., Lebre, MC., Tibben, M., Beijnen, JH., & Schinkel, AH. (2024). Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics, 21(4), 1952-1964. https://doi.org/10.1021/acs.molpharmaceut.3c01205

Joosse, I. R., van den Ham, H. A., Mantel-Teeuwisse, A. K., & Suleman, F. (2024). The caregiver’s experience of childhood cancer treatment in South Africa. Journal of Pharmaceutical Policy and Practice, 17(1), Article 2312382. https://doi.org/10.1080/20523211.2024.2312382

Brinkhuis, F., Goettsch, W. G., Mantel - Teeuwisse, A., & Bloem, L. T. (2024). Added benefit and revenues of oncology drugs approved by the European Medicines Agency between 1995 and 2020: retrospective cohort study. The BMJ, 384, Article e077391. https://doi.org/10.1136/bmj-2023-077391

Bouwman, L., Sepodes, B., Leufkens, H., & Torre, C. (2024). Trends in orphan medicinal products approvals in the European Union between 2010–2022. Orphanet Journal of Rare Diseases, 19(1), Article 91. https://doi.org/10.1186/s13023-024-03095-z

Lelie-van der Zande, R., Teichert, M., & Bouvy, M. (2024). Rol voor openbaar apotheker als behandelaar bij recidiverende blaasontsteking? Huisarts en Wetenschap, 67(3), 33-35. https://doi.org/10.1007/s12445-024-2754-9

Jiu, L., Hartog, M., Wang, J., Vreman, R. A., Klungel, O. H., Mantel-Teeuwisse, A. K., & Goettsch, W. G. (2024). Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis. BMJ Open, 14(2), Article e075173. https://doi.org/10.1136/bmjopen-2023-075173

Knikman, JE., Lopez-Yurda, M., Meulendijks, D., Schellens, JHM., Beijnen, J., Cats, A., & Guchelaar, HJ. (2024). A Nomogram to Predict Severe Toxicity in DPYD Wild-Type Patients Treated With Capecitabine-Based Anticancer Regimens. Clinical Pharmacology & Therapeutics, 115(2), 269-277. https://doi.org/10.1002/cpt.3100

Lin, LS., van der Meer, EKO., Steeghs, N., Beijnen, JH., & Huitema, A. D. R. (2024). Are novel oral oncolytics underdosed in obese patients? Cancer Chemotherapy and Pharmacology, 93(2), 129-136. https://doi.org/10.1007/s00280-023-04601-z

Lin, L., Barkman, HJ., Smit, EF., de Langen, AJ., Steeghs, N., Beijnen, JH., & Huitema, ADR. (2024). Clinical Relevance of High Plasma Trough Levels of the Kinase Inhibitors Crizotinib, Alectinib, Osimertinib, Dabrafenib, and Trametinib in NSCLC Patients. Therapeutic Drug Monitoring, 46(1), 73-79. https://doi.org/10.1097/FTD.0000000000001120

Mertens, J. F., Kempen, T. G. H., Koster, E. S., Deneer, V. H. M., Bouvy, M. L., & van Gelder, T. (2024). Cognitive processes in pharmacists’ clinical decision-making. Research in Social and Administrative Pharmacy, 20(2), 105-114. https://doi.org/10.1016/j.sapharm.2023.10.007

Cam, H., Gillespie, U., Sporrong, S. K., Nielsen, E., Kempen, T. G. H., & Franzon, K. (2024). Failure to Involve Older Hospitalised Patients in Medication Decisions - a Change of Approach is Called For. Research in Social and Administrative Pharmacy, 20(2), 216-217. https://doi.org/10.1016/j.sapharm.2023.09.016

Rasmussen, N. H., Driessen, J. H. M., Kvist, A. V., Souverein, P. C., van den Bergh, J., & Vestergaard, P. (2024). Fracture patterns in adult onset type 1 diabetes and associated risk factors - A nationwide cohort study. Bone, 179, 1-10. Article 116977. https://doi.org/10.1016/j.bone.2023.116977

van der Heijden, L. T., Ribbers, C. A., Vermunt, M. A. C., Pluim, D., Acda, M., Tibben, M., Rosing, H., Douma, J. A. J., Naipal, K., Bergman, A. M., Beijnen, J. H., Huitema, A. D. R., & Opdam, F. L. (2024). Is Higher Docetaxel Clearance in Prostate Cancer Patients Explained by Higher CYP3A? An In Vivo Phenotyping Study with Midazolam. Journal of Clinical Pharmacology, 64(2), 155-163. https://doi.org/10.1002/jcph.2362

Minjon, L. (2024). Monitoring antipsychotica bij jongeren kan veel beter. Pharmaceutisch Weekblad, 159(7), 12-14. https://www.pw.nl/achtergrond/2024/monitoring-antipsychotica-bij-jongeren-kan-veel-beter

Mertens, J., Koster, E., Deneer, V., Kempen, T., Bouvy, M., & van Gelder, T. (2024). 'MEER FOCUS OP KLINISCHE BESLUITVORMING IN ONDERWIJS'. Pharmaceutisch Weekblad, 159(4), 14-16.

Loos, NHC., Martins, MLF., de Jong, D., Lebre, MC., Tibben, M., Beijnen, JH., & Schinkel, A. H. (2024). Coadministration of ABCB1/P-glycoprotein inhibitor elacridar improves tissue distribution of ritonavir-boosted oral cabazitaxel in mice. International Journal of Pharmaceutics, 650, Article 123708. https://doi.org/10.1016/j.ijpharm.2023.123708

Buhl, C., Jacobsen, R., Almarsdóttir, A. B., Abtahi, S., Andersen, A., Deligianni, E., Dermiki-Gkana, F., Kontogiorgis, C., Oikonomou, C., Kursite, M., Poplavska, E., Hegger, I., Goot, M. V. D., Ferreira, P. B. S., Ribeiro-Vaz, I., Silva, A. M., Kos, M., Lipovec, N. Č., Vliet, E. V., & Alves, T. L. (2024). Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions: A cross-sectional study in six EU member states. Vaccine, 42(3), 556-563. https://doi.org/10.1016/j.vaccine.2023.12.065

Narsai, K., Masekela, F. B., Leufkens, H. G. M., & Mantel-Teeuwisse, A. K. (2024). Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation. BMC Health Services Research, 24(1), Article 111. https://doi.org/10.1186/s12913-024-10585-0

van Veelen, A., Veerman, G. D. M., Verschueren, M. V., Gulikers, J. L., Steendam, C. M. J., Brouns, A. J. W. M., Dursun, S., Paats, M. S., Tjan-Heijnen, V. C. G., van der Leest, C., Dingemans, A. M. C., Mathijssen, R. H. J., van de Garde, E. M. W., Souverein, P., Driessen, J. H. M., Hendriks, L. E. L., van Geel, R. M. J. M., & Croes, S. (2024). Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer. International Journal of Cancer, 154(2), 332-342. https://doi.org/10.1002/ijc.34742

Trials@Home Consortium, van Rijssel, T. I., van Thiel, G. J. M. W., Gardarsdottir, H., & van Delden, J. J. M. (2024). Which Benefits Can Justify Risks in Research? American Journal of Bioethics, 1-11. Advance online publication. https://doi.org/10.1080/15265161.2023.2296404

Abdullah-Koolmees, H., Mekel, V. C. C., I Veldkamp, A., Caris, M. G., & Swart, E. L. (2024). A case report: Management of carbamazepine intoxication using hemodialysis followed by continuous venovenous hemodialysis. SAGE Open Medical Case Reports, 12, 1-5. https://doi.org/10.1177/2050313X241229844

Retmana, I. A., Çelebi, N., Rijmers, J., Schinkel, A. H., Beijnen, J. H., & Sparidans, R. W. (2024). Development and validation of an LC-MS/MS method for the quantification of KRASG12C inhibitor opnurasib in several mouse matrices and its application in a pharmacokinetic mouse study. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 1232, 1-11. Article 123964. https://doi.org/10.1016/j.jchromb.2023.123964

Costa, E., Moja, L., Wirtz, V. J., van den Ham, H. A., Huttner, B., Magrini, N., & Leufkens, H. G. (2024). Uptake of orphan drugs in the WHO essential medicines lists. Bulletin of the World Health Organization, 102(1), 22-31. https://doi.org/10.2471/BLT.23.289731

Zhang, P., Kuil, LE., Buil, LCM., Freriks, S., Beijnen, JH., van Tellingen, O., & de Gooijer, MC. (2024). Acquired and intrinsic resistance to vemurafenib in BRAFV600E-driven melanoma brain metastases. FEBS Open Bio, 14(1), 96-111. https://doi.org/10.1002/2211-5463.13730

Lu, Z., Fu, LW., Huang, LX., Ke, WJ., Leng, XY., Li, YW., Lin, YF., Marra, CM., Tian, T., Wang, JF., Wang, LY., Weng, WJ., Wu, JX., Wu, XS., Yang, B., Yang, LG., Yang, LY., Zhang, XH., Zhou, XY., & Zou, HC. (2024). Development, validation and clinical utility of a suite of simplified clinical diagnostic models for neurosyphilis based on multiple guidelines. Sexually Transmitted Diseases, 51(1), S400-S401. https://doi.org/10.1097/OLQ.0000000000001886

Manson, L., Nijenhuis, M., Soree, B., de Boer-Veger, N., Buunk, AM., Houwink, E., Risselada, A., Rongen, G., Van Schaik, R., Swen, J., Touw, D., Van der Weide, J., van Westrhenen, R., Deneer, V., & Guchelaar, HJ. (2024). EJHG series: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C9 and HLA and anti-epileptic drugs. European Journal of Human Genetics, 32, 683-683. https://doi.org/10.1038/s41431-023-01482-x

Aakjær, M., De Bruin, M. L., & Andersen, M. (2024). Epidemiological surveillance of drug safety using cumulative sequential analysis in electronic healthcare data. Basic and Clinical Pharmacology and Toxicology, 134(1), 129-140. https://doi.org/10.1111/bcpt.13955

Damoiseaux, D., Schinkel, A. H., Beijnen, J. H., Huitema, A. D. R., & Dorlo, T. P. C. (2024). Predictability of human exposure by human-CYP3A4-transgenic mouse models: A meta-analysis. Clinical and Translational Science, 17(1), Article e13668. https://doi.org/10.1111/cts.13668

ROAD Study Group (2024). Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study. JAMA Oncology, 10(1), 87-94. https://doi.org/10.1001/jamaoncol.2023.4865

Beunk, L., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A.-M., Guchelaar, H. J., Houwink, E. J. F., Risselada, A., Rongen, G. A. P. J. M., van Schaik, R. H. N., Swen, J. J., Touw, D., van Westrhenen, R., Deneer, V. H. M., & van der Weide, J. (2024). Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics. European Journal of Human Genetics, 32(3), 278–285. https://doi.org/10.1038/s41431-023-01347-3

van der Pol, K. H., Nijenhuis, M., Soree, B., de Boer-Veger, N. J., Buunk, A. M., Guchelaar, H.-J., Risselada, A., van Schaik, R. H. N., Swen, J. J., Touw, D., van der Weide, J., van Westrhenen, R., Deneer, V. H. M., Houwink, E. J. F., & Rongen, G. A. (2024). Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. European Journal of Human Genetics, 32(2), 155-162. https://doi.org/10.1038/s41431-022-01180-0

Petro, E., Perumal-Pillay, V., Mantel-Teeuwisse, A. K., van den Ham, H. A., & Suleman, F. (2024). Evaluation of alignment of the reimbursement medicines list for children in Albania with the WHO essential medicines list for children. Journal of Pharmaceutical Policy and Practice, 17(1), 1-18. Article 2290100. https://doi.org/10.1080/20523211.2023.2290100

Kaló, Z., Niewada, M., Bereczky, T., Goettsch, W., Vreman, R. A., Xoxi, E., Trusheim, M., Callenbach, M. H. E., Nagy, L., & Simoens, S. (2024). Importance of aligning the implementation of new payment models for innovative pharmaceuticals in European countries. Expert Review of Pharmacoeconomics and Outcomes Research, 24(2), 181-187. https://doi.org/10.1080/14737167.2023.2282680

Hogervorst, M. A., Vreman, R., Heikkinen, I., & Oortwijn, W. (2024). Response to uncertainty management in regulatory and health technology assessment decision-making on drugs: Guidance of the HTAi-DIA Working Group - Author's reply. International Journal of Technology Assessment in Health Care, 40(1), 1-2. Article e1. https://doi.org/10.1017/S0266462323002817

van Dommelen, J. E. M., Grootjans, H., Uijtendaal, E. V., Ruigrok, D., Luijk, B., van Luin, M., Bult, W., de Lange, D. W., Kusadasi, N., Droogh, J. M., Egberts, T. C. G., Verschuuren, E. A. M., & Sikma, M. A. (2024). Tacrolimus Variability and Clinical Outcomes in the Early Post-lung Transplantation Period: Oral Versus Continuous Intravenous Administration. Clinical Pharmacokinetics, 63(5), 683-693. https://doi.org/10.1007/s40262-024-01368-1

van der Heijden, LT., Opdam, FL., Beijnen, JH., & Huitema, ADR. (2024). The Use of Microdosing for In vivo Phenotyping of Cytochrome P450 Enzymes: Where Do We Stand? A Narrative Review. European Journal of Drug Metabolism and Pharmacokinetics, 49(4), 407–418. https://doi.org/10.1007/s13318-024-00896-2